Subclinical Cushing's disease with amelioration of metabolic comorbidities after removal of pituitary tumor

Internal Medicine

Volumn 45, Issue 21, 2006, Pages 1231-1235

  Minami, Isao ^a   Tateno, Toru ^a   Yoshimoto, Takanobu ^a   Doi, Masaru ^a   Izumiyama, Hajime ^a   Akashi, Takumi ^a   Hirata, Yukio ^a  

^a Tokyo Medical and Dental University Graduate School ^*  (Japan)

Author keywords

Adrenocorticotropic hormone (ACTH); Cortisol; Pituitary incidentaloma; Transsphenoidal surgery

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE;

ADRENAL CORTEX ADENOMA; ADULT; ARTICLE; CASE REPORT; CHROMOPHOBE ADENOMA; CIRCADIAN RHYTHM; COMORBIDITY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; CUSHING DISEASE; FEMALE; HOSPITAL ADMISSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; HYPOPHYSIS TUMOR; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREACTIVITY; IMPAIRED GLUCOSE TOLERANCE; OBESITY; POSTOPERATIVE PERIOD; TRANSSPHENOIDAL SURGERY; BLOOD; GLUCOSE INTOLERANCE; HYPOPHYSIS ADRENAL SYSTEM; METABOLISM; MIDDLE AGED;

FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERTENSION; MIDDLE AGED; OBESITY; PITUITARY ACTH HYPERSECRETION; PITUITARY NEOPLASMS; PITUITARY-ADRENAL SYSTEM;

EID: 33845233614     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1809     Document Type: Article

References (17)

1. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W. Preclinical Cushing's syndrome in adrenal "incidentaloma": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 75: 826-832, 1992.
2. Terzolo M, Reimondo G, Bovio S, Angeli A. Subclinical Cushing's syndrome. Pituitary 7: 217-223, 2004.
3. Nagai T, Imamura M, Misumi S, Mori M. Subclinical Cushing's disease accompanied by malignant hypertension and diabetes mellitus. Intern Med 41: 566-570, 2002.
4. Takao T, Mimoto T, Yamamoto M, Hashimoto K. Prectinical Cushing's disease. Arch Intern Med 161: 892-893, 2001.
5. Kageyama K, Moriyama T, Sakihara S, Kawashima S, Suda T. A case of preclinical Cushing's disease, accompanied with thyroid papillary carcinoma and adrenal incidentaloma. Endocrine J 50: 325-331, 2003.
6. Fuller PJ, Lim AT, Barlow JW, et al. A pituitary tumor producing high molecular weight adrenocorticotropin-related peptides: clinical and cell culture studies. J Clin Endocrinol Metab 58: 134-142, 1984.
7. Reincke M, Allolio B, Saeger W, Kaulen D, Winkelmann W. A Pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing's disease. J Clin Endocrinol Metab 65: 1296-1300, 1987.
8. Ueyama T, Tamaki N, Kondoh T, Kurata H. Large and invasive silent corticotroph-cell adenoma with elevated serum ACTH: a case report. Surg Neurol 50: 30-31, 1998.
9. Yamakita N, Murai T, Kawamura S, et al. High molecular weight corticotropin measured with immunoradiometric assay in a patient with asymptomatic pituitary corticotropinoma. Endocrine J 46: 563-571, 1999.
10. Ricketts ML, Verhaeg JM, Bujalska I, Howie AJ, Rainey WE, Stewart PM. Immunohistochemical localization of type 1 11beta-hydroxysteroid. dehydrogenase in human tissues. J Clin Endocrinol Metab 83: 1325-1335, 1998.
11. Cooper MS, Walker BR, Holder G, O'Halloran D, Shackleton CH. 11beta-hydroxysteroid dehydrogenase activity in human bone. Bone 27: 375-381, 2000.
12. Tomlinson JW, Draper N, Mackie J, et al. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion. J Clin Endocrinol Metab 87: 57-62, 2002.
13. Vaughan NJ, Laroche CM, Goodman I, Davis MJ, Jenkins JS. Pituitary Cushing's disease arising from a previously non-functional corticotrophic chromophobe adenoma. Chn Endocrinol (Oxf) 22: 147-153, 1985.
14. Tauchmanova L, Rossi R, Biondi B, et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87: 4872-4878, 2002.
15. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553, 1998.
16. Stewart PM. Tissue-specific Cushing's syndrome, 11β-hydroxy-steroid dehydrogenases and the redefinition of corticosteroid hormone action. Eur J Endocrinol 149: 163-168, 2003.
17. Putignano P, Pecori GF, Cavagnini F. Tissue-specific dysregulation of 11beta-hydroxysteroid dehydrogenase type 1 and pathogenesis of the metabolic syndrome. J Endocrinol Invest 27: 969-974, 2004.